Attached files
file | filename |
---|---|
10-K - 10-K - MEI Pharma, Inc. | meip-20210630.htm |
EX-32.1 - EX-32.1 - MEI Pharma, Inc. | meip-20210630ex32_1.htm |
EX-31.2 - EX-31.2 - MEI Pharma, Inc. | meip-20210630ex31_2.htm |
EX-31.1 - EX-31.1 - MEI Pharma, Inc. | meip-20210630ex31_1.htm |
EX-23.1 - EX-23.1 - MEI Pharma, Inc. | meip-20210630ex23_1.htm |
EX-10.5 - EX-10.5 - MEI Pharma, Inc. | meip-20210630ex10_5.htm |
Exhibit 10.6
April 29, 2021
Richard G. Ghalie, MD, MBA
4755 Natalie Drive
San Diego, CA 92115
Dear Richard,
In connection with your promotion to Chief Medical Officer, this Amendment 2021-1 to your February 17, 2016 employment letter agreement between MEI Pharm, Inc. (the "MEI") and you (the "Employment Letter") hereby amends certain of the terms of the Employment Letter, effective May 3, 2021, unless otherwise noted below, as follows:
All other terms of the Employment letter not amended as set forth above shall remain in full force and effect.
Sincerely,
/s/ Daniel P. Gold
Daniel P. Gold, Ph.D.
President & CEO
MEI Pharma, Inc.
Agreed and accepted: |
|
/s/ Richard G. Ghalie |
|
Date: |
|
April 29, 2021 |
|
|
Richard G. Ghalie, MD, MBA |
|
|
|
|
11455 El Camino Real, Suite 250, San Diego, CA 92130
Tel: 858 369 7100 Fax: 858 369 7101 Website: www.meipharma.com